Clinical trials
Terminated Phase 1/2 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 9 |
| 2016 | 2 |
| 2017 | 12 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 107 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 6 |
| Altor BioScience | 4 |
| Sanofi | 4 |
| Shenzhen Geno-Immune Medical Institute | 4 |
| National Cancer Institute (NCI) | 3 |
| Sumitomo Pharma America, Inc. | 3 |
| AHS Cancer Control Alberta | 2 |
| Adherex Technologies, Inc. | 2 |
| CytomX Therapeutics | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 107 |
| Neoplasm Metastasis | 13 |
| Recurrence | 13 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Melanoma | 10 |
| Lymphoma | 8 |
| Ovarian Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Head and Neck Neoplasms | 6 |
| Leukemia | 6 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.